LIQID Medical’s novel ocular implant, the OptiShunt, shunts excess ocular fluid in the eye to a naturally occurring anatomical space behind the eye. This creates a self-regulating system that provides highly effective pressure control while avoiding the complications and costs associated with traditional devices. Phase one clinical trials indicate that the OptiShunt is 50% more effective at lowering eye pressure than existing devices.
BIO DOUBLE HELIX SPONSORS
BIO HELIX SPONSORS
